Series D funding round for Cambridge Epigenetix raising $88M in November 2021
Series D funding round for Cambridge Epigenetix raising $88M in November 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Nikolaj Nyholm |
| Angel | Pete Moore |
| Angel | Erik Nordlander |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$139M
Top Valuation
-
Cambridge Epigenetix raised $88M in a Series D round.
The round was announced on 11/01/21.